Ma et al. (89) demonstrated that high doses of VC administered via tail vein injection in glioma model mice led to increased activity of checkpoint kinase 2 (CHK2) and histone 2AX (H2AX), indicating that high-dose VC caused DNA damage by elevating intracellular ROS levels. This evidence concerns the gene CHEK2 and glioma.